We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Inflammatory Markers Correlated with SCA Pain Intensity

By LabMedica International staff writers
Posted on 17 Nov 2016
Sickle cell anemia (SCA) is a hereditary hemolytic anemia where the synthesis of hemoglobin (Hb) is abnormal and the inheritance can be heterozygous (HbS) or homozygous (HbSS). More...
Homozygous patients with SCA often develop vaso-occlusive crises (VOCs) and recurrent episodes of hemolysis causing multi-organ infarction and dysfunction.

Bone pain in patients with SCA varies from acute clinical painful VOC or osteomyelitis to more chronic and debilitating disease, such as osteoporosis, osteopenia and osteonecrosis, and chronic infections with impaired growth. Inflammatory markers are increased during VOC in adult patients with SCA, but this is not clear in clinical steady state.

Scientists at the Arabian Gulf University (Manama, Bahrain) studied 46 patients of whom 27 were females with SCA who age ranged from 12 to 40 years and they were compared with 46 patients with bone pain but proven to be with no SCA. Patients were included if they were diagnosed with sickle cell disease (SCD) with homozygous hemoglobin (HbSS) using Hb electrophoresis and solubility screening test for sickling.

Blood samples were obtained at base line, one month and three months after enrollment to determine the level of tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), C-reactive protein (CRP), Hb, reticulocyte count, lactate dehydrogenase (LDH), vitamin D3, parathormone (PTH) and serum ferritin. Patients were examined clinically for bone pain or tenderness in the peripheral joints, chest or vertebrae within the last two days prior to assessment. Serum TNF-α and IL-1 levels were measured using the enzyme-linked immunosorbent assay technique (enzyme-amplified sensitivity immunoassay kits; BioSource Europe SA, Nivelles, Belgium). Quantification of PTH in serum was performed by enzyme-linked immunosorbent assay (Creative Diagnostics, Shirley, NY, USA).

The investigators found vitamin D3 and Hb were lower in SCA patients, 17.04 ± 5.77 versus 37.6 ± 4.83 ng/L and 7.96 ± 0.3 versus 8.44±0.27 g/dL, respectively. The inflammatory markers showed significantly higher level of TNF-α (56.52 ± 5.43 pg/mL), IL-1 (44.17 ± 4.54 pg/mL and CRP 3.20 ± 0.72 mg/L. WBC, LDH and reticulocyte count were also significantly higher. There was a significant positive correlation between serum levels of TNF-α and bone pain frequency and serum level of IL-1.

The authors concluded that there was a strong positive correlation between the inflammatory biomarkers, TNF-α, IL-1 and WBC, and bone pain frequency in steady state in adult patients with SCA. QT dispersion (QTd), a marker of ventricular recovery times, was significantly longer among patients with SCA who had more than three hospitalizations over a 6-month interval. The study was published on October 31, 2016, in the Journal of Blood Medicine.

Related Links:
Arabian Gulf University
BioSource Europe
Creative Diagnostics


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.